@article{59c101f05ffe4b709041af6cd13e6fdb,
title = "CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer",
abstract = "Although CD4+ T cell “help” is crucial to sustain antiviral immunity, the mechanisms by which CD4+ T cells regulate CD8+ T cell differentiation during chronic infection remain elusive. Here, using single-cell RNA sequencing, we show that CD8+ T cells responding to chronic infection were more heterogeneous than previously appreciated. Importantly, our findings uncovered the formation of a CX3CR1-expressing CD8+ T cell subset that exhibited potent cytolytic function and was required for viral control. Notably, our data further demonstrate that formation of this cytotoxic subset was critically dependent on CD4+ T cell help via interleukin-21 (IL-21) and that exploitation of this developmental pathway could be used therapeutically to enhance the killer function of CD8+ T cells infiltrated into the tumor. These findings uncover additional molecular mechanisms of how “CD4+ T cell help” regulates CD8+ T cell differentiation during persistent infection and have implications toward optimizing the generation of protective CD8+ T cells in immunotherapy.",
keywords = "CD4 T cell help, CD8 T cell heterogeneity, LCMV Cl13",
author = "Ryan Zander and David Schauder and Gang Xin and Christine Nguyen and Xiaopeng Wu and Allan Zajac and Weiguo Cui",
note = "Funding Information: This work is supported by NIH grants AI125741 (W.C.) and DK108557 (D.S.) and by American Cancer Society (ACS) Research Scholar Grant and A Healthier Wisconsin (AHW) Grant (W.C.). R.Z. is supported by the Cancer Research Institute Irvington Fellowship. G.X. is supported by The Elizabeth Elser Doolittle Postdoctoral Fellowship . D.S. is a member of the Medical Scientist Training Program at MCW, which is partially supported by a training grant from NIGMS T32-GM080202 . This research was completed in part with computational resources and technical support provided by the Research Computing Center at MCW. Funding Information: This work is supported by NIH grants AI125741 (W.C.) and DK108557 (D.S.) and by American Cancer Society (ACS) Research Scholar Grant and A Healthier Wisconsin (AHW) Grant (W.C.). R.Z. is supported by the Cancer Research Institute Irvington Fellowship. G.X. is supported by The Elizabeth Elser Doolittle Postdoctoral Fellowship. D.S. is a member of the Medical Scientist Training Program at MCW, which is partially supported by a training grant from NIGMS T32-GM080202. This research was completed in part with computational resources and technical support provided by the Research Computing Center at MCW. R.Z. D.S. G.X. C.N. X.W. and W.C. designed and performed the experiments and analyzed the data. D.S. analyzed RNA-seq datasets. A.Z. provided helpful insight and contributed with key reagents, including IL-21?/? P14 cells and bone marrow from IL-21?/? mice. R.Z. D.S. and W.C. wrote the manuscript. W.C. supervised the study. The authors declare no competing interests. Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",
year = "2019",
month = dec,
day = "17",
doi = "10.1016/j.immuni.2019.10.009",
language = "English (US)",
volume = "51",
pages = "1028--1042.e4",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "6",
}